AzTrials
AzTrials

EdentulousNCT02850458

Clinical Results of Implant-retained Mandibular Overdentures in Edentulous Patients

An observational study of Edentulous, run by Ji-hua Chen at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the clinical results of implant-retained mandibular overdentures in edentulous patients. Read more about this study

Who is it for?
Ages 45 to 83 yearsHealthy volunteers can take part
Conditions the study is for
Edentulous
What is being tested?
implant-retained overdentures
Type of treatment
Medical device
How many people
54 participants
Where
1 siteChina
Study dates
Feb 2016to Aug 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 83 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients treated with implant retained overdentures at the Department of Prosthodontics, School of Stomatology of the Fourth Military Medical University between July 2011 to May 2014.

Who may be able to join

  • Patients treated with implant retained overdentures
  • With the ability to read and sign the informed consent document

Who cannot join

  • Jaw radiotherapy treatment before and after implanting
  • Patients who suffered with mental and psychological disease will influence their oral health normal maintenance
  • Can not read and sign the informed consent document

Trial locations and contacts

1 site in 1 country.

Ji hua chen, PhD contact

029-84776329

hchen@fmmu.edu.cn

China1 site, 1 recruiting
  • Stomatological Hospital of Fourth Military Medical University

    Xi’an, Shanxi

    ji hua chen, PhD, 029-84776329, jhchen@fmmu.edu.cn

    huan zhou, 029-84776128, zhouhuan113@126.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Results of Implant-retained Mandibular Overdentures in Edentulous Patients: A 5-year Retrospective Study

The purpose of this study is to evaluate the clinical results of implant-retained mandibular overdentures in edentulous patients.

Read the detailed description

The survival of implants,condition of the peri-implant soft tissue were evaluated. And patients' perceptions regarding the outcome were assessed on visual analog scales (VAS), oral health impact profile-14 (OHIP) and semantic differential scale questionnaires.

Conditions
Edentulous
Being tested
implant-retained overdentures
Medical subject headings
Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • implant-retained overdenturesDevice

    patients treated with an implant-retained overdenture in the mandible

Study groups in NCT02850458
Study groupRoleWhat they receive
implant retained-overdentures with the attachment of barpatients treated with implant-retained overdentures,and the attachment is bar
Receives: Device: implant-retained overdentures
implant retained-overdentures with the attachment of magnetpatients treated with implant-retained overdentures,and the attachment is magnet
Receives: Device: implant-retained overdentures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival of implants

    Measured: through study completion, an average of 1 year

Secondary outcomes (3)
  1. Gingival Bleeding on Probing

    Gingival bleeding on probing (BOP) using the modified sulcus bleeding index for implants. Scale equals 0 = No bleeding when periodontal probe is passed along the gingival margin;1 = Isolated bleeding spots visible;2 = Blood forms a confluent red line on the gingival margin;3 = Heavy or profuse bleeding

    Measured: through study completion, an average of 1 year

  2. Pocket depths

    Pocket depths measured around implants in millimeter (mm)

    Measured: through study completion, an average of 1 year

  3. Marginal bone loss

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionFeb 2017 (estimated)
  4. Study completionAug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02850458
Sponsor's protocol ID
IRB-REV-2016036
Status last verified
Feb 2017
First submitted
25 Jul 2016
Last updated
7 Feb 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Edentulous, run by Ji-hua Chen at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ji hua chen, PhD (029-84776329, hchen@fmmu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival of implants (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in